ArticleJournal of clinical pharmacology2020

Results From a First-in-Human Study of BNZ-1, a Selective Multicytokine Inhibitor Targeting Members of the Common Gamma (γc) Family of Cytokines.

Paul A Frohna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.